Acceligen successfully breeds gene-edited pigs with PRRS resistance

Acceligen, a leading innovator in sustainable agriculture, is proud to announce the breeding of gene-edited pigs with resistance to porcine reproductive and respiratory syndrome. This breakthrough represents a significant step forward in the pursuit for sustainable and ethical pork production.

PRRS is the most devastating disease to the swine industry in the United States, affecting not only the productivity of pigs, but also their health and wellness.  This regularly occurring and complex disease has been documented to cause an estimated $500 million USD of losses to the pork producers, thus affecting the food security of countless people around the world.